Global Multiplex Immunofluorescence Assay Market Growth (Status and Outlook) 2025-2031

The global Multiplex Immunofluorescence Assay market size is predicted to grow from US$ 1779 million in 2025 to US$ 2381 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.

Global key players of multiplex immunofluorescence assay include Fluidigm, Akoya Biosciences. North America is the largest market, with a share about 35%, followed by Asia Pacific and Europe with the share about 30% and 25%.

LPI (LP Information)' newest research report, the “Multiplex Immunofluorescence Assay Industry Forecast” looks at past sales and reviews total world Multiplex Immunofluorescence Assay sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiplex Immunofluorescence Assay sales for 2025 through 2031. With Multiplex Immunofluorescence Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiplex Immunofluorescence Assay industry.

This Insight Report provides a comprehensive analysis of the global Multiplex Immunofluorescence Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiplex Immunofluorescence Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiplex Immunofluorescence Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiplex Immunofluorescence Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiplex Immunofluorescence Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiplex Immunofluorescence Assay market by product type, application, key players and key regions and countries.

Segmentation by Type:
Material
Equipment
Software and Service

Segmentation by Application:
Academic and Research Institution
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fluidigm
Akoya Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.